PT-141

PT-141 (Bremelanotide) is a cyclic peptide melanocortin receptor agonist that serves as a valuable research tool for exploring central signaling pathways related to sexual behavior, appetite, and energy balance. As a focused analog studied in neuroendocrine contexts, it provides researchers with a precise model for investigating receptor activity and hypothalamic–pituitary signaling dynamics.

Features:

• High Purity: Research-grade formulation with ≥ 98% purity.
• Stable Formulation: Supplied as lyophilized powder for ease of storage and handling.
• Appearance: White to off-white powder, stable under recommended conditions.
• Storage: Store in a cool, dry place; refrigerate after reconstitution.

Advantages:

PT-141 offers a controlled model for studies of melanocortin receptor signaling without the confounders of broader peptide systems. Its defined composition supports reproducible assay conditions and consistent protocol development across neuroendocrine research settings.

Research Applications:

Researchers utilize PT-141 to investigate melanocortin pathway modulation, receptor binding characteristics, and downstream signaling relevant to central regulation of behavior and energy homeostasis. Its concise structure enables reliable comparisons across in vitro and preclinical study designs.